Sirolimus

Sirolimus API

Sirolimus / Rapamycin for facial angiofibromas A Sirolimus vaseline® 0.1% jelly produced by pharmacies according to an prescription shows success in the treatment of facial angiofibromas. Facial angiofirbomas are a symptom of tuberous sclerosis (TSC also Pringle-Bourneville disease). Tuberous sclerosis is a multi-system disease. At least for the treatment of facial angiofibromas, a rapamycin vaseline® […]

Read more

Combat COVID-19 with the natural compound OSW-1!?

Oxysterol-binding Protein (OSBP), required for the cellular replication of many types of viruses can be inhibited by the natrual compound (OSW-1). The OSW-1 induced reduction of OSBP inhibit Enterovirus replication prophylactically in cells. These are the findings published in Antiviral Research 117 (2015) 110-114 and Antiviral Research 170 (2019) 104548. We assume, that COVID-19 (CORONAVIRUS) […]

Read more

Alpine Winter Conference

Visit us at the 2nd Alpine Winter Conference in St. Anton, taking place Jan. 19.- Jan 23, 2020 The Conference topics will include: Accelerating Drug Discovery by Intelligence Augmentation Drug Discovery Tales Frontiers of Synthetic Chemistry Innovation and Inspiration from Natural Products Predictive ADME Sciences: Striking a Balance Between in Silico and Experimental Work? Protein […]

Read more

Rapamycin – Active Pharmaceutical Ingredient

We are pleased to offer Rapamycin as GMP/API grade (active pharmaceutical ingredient) in small quantities (5 g / 25 g). Especially pharmacies working in the field of Tuberous Sclerosis treatment (TSC, Tuberous Sclerosis Complex, Pringle-Bournveville’s disease), we would like to offer the best EU pharmaceutical quality in acceptable quantities. For drug-eluting stents (DES) coating companies, […]

Read more